Sanford C. Bernstein Issues Positive Forecast for Atlassian (NASDAQ:TEAM) Stock Price

Atlassian (NASDAQ:TEAM) had its price objective lifted by Sanford C. Bernstein from $290.00 to $304.00 in a research report report published on Tuesday morning,Benzinga reports. Sanford C. Bernstein currently has an outperform rating on the technology company’s stock.

Several other analysts also recently weighed in on the stock. Raymond James Financial dropped their target price on shares of Atlassian from $300.00 to $250.00 and set an “outperform” rating on the stock in a research report on Friday, August 8th. Citigroup restated a “buy” rating on shares of Atlassian in a research report on Wednesday, October 22nd. Wall Street Zen upgraded Atlassian from a “hold” rating to a “buy” rating in a report on Saturday, September 13th. Piper Sandler reaffirmed an “overweight” rating and set a $300.00 target price on shares of Atlassian in a report on Friday, October 31st. Finally, TD Cowen cut their price target on Atlassian from $220.00 to $205.00 and set a “hold” rating for the company in a report on Monday, October 27th. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $240.00.

Atlassian Price Performance

Shares of TEAM stock opened at $148.75 on Tuesday. The stock’s 50-day moving average is $160.32 and its 200 day moving average is $182.84. Atlassian has a 1-year low of $144.32 and a 1-year high of $326.00. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.26 and a quick ratio of 1.26. The company has a market cap of $39.14 billion, a P/E ratio of -209.50, a PEG ratio of 34.63 and a beta of 0.95.

Atlassian (NASDAQ:TEAM) last released its quarterly earnings results on Thursday, October 30th. The technology company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.83 by $0.21. Atlassian had a negative net margin of 3.38% and a negative return on equity of 7.11%. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same period in the prior year, the firm posted $0.77 earnings per share. The company’s quarterly revenue was up 20.6% on a year-over-year basis. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts predict that Atlassian will post -0.34 earnings per share for the current fiscal year.

Insider Transactions at Atlassian

In related news, CEO Michael Cannon-Brookes sold 7,665 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $171.13, for a total transaction of $1,311,711.45. Following the completion of the transaction, the chief executive officer owned 168,630 shares of the company’s stock, valued at approximately $28,857,651.90. This trade represents a 4.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Scott Farquhar sold 7,665 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $171.13, for a total value of $1,311,711.45. Following the completion of the sale, the director directly owned 168,630 shares in the company, valued at approximately $28,857,651.90. The trade was a 4.35% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have purchased 4,497 shares of company stock worth $742,375 and have sold 574,422 shares worth $93,484,396. Company insiders own 36.66% of the company’s stock.

Institutional Investors Weigh In On Atlassian

Several institutional investors and hedge funds have recently modified their holdings of TEAM. Capco Asset Management LLC purchased a new stake in Atlassian during the second quarter worth about $25,000. Physician Wealth Advisors Inc. grew its holdings in shares of Atlassian by 60.4% in the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after purchasing an additional 61 shares in the last quarter. Atlantic Union Bankshares Corp grew its holdings in shares of Atlassian by 19,900.0% in the third quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after purchasing an additional 199 shares in the last quarter. Smithfield Trust Co increased its stake in Atlassian by 90.7% during the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock worth $34,000 after buying an additional 78 shares during the period. Finally, Geneos Wealth Management Inc. lifted its holdings in Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after buying an additional 161 shares in the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

About Atlassian

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.